Andrew James King, Chief Scientific Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 10,000 shares at $25.82 ($258K) on 2023-01-03, disclosed to the SEC on 2023-01-04.
Open-market sale of $258k KDNY by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KDNY | SELL | 2023-02-15 | $57K | — | Filing → |
| KDNY | SELL | 2023-02-02 | $160K | — | Filing → |
| KDNY | SELL | 2022-10-11 | $140K | — | Filing → |